US Stock MarketDetailed Quotes

Moleculin Biotech (MBRX)

Watchlist
  • 2.430
  • +0.020+0.83%
Close Apr 8 16:00 ET
12.97MMarket Cap-0.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Moleculin Biotech (MBRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-5.77%25.1M
13.40%7.53M
-17.22%5.91M
-7.52%5.72M
-10.99%5.94M
-10.09%26.64M
-25.52%6.64M
19.98%7.14M
-3.53%6.19M
-20.07%6.68M
Selling and administrative expenses
3.82%9.12M
11.59%2.41M
-1.15%2.15M
1.31%2.09M
3.51%2.48M
-12.29%8.79M
-4.22%2.16M
-17.57%2.17M
-17.17%2.06M
-9.25%2.39M
-General and administrative expense
3.82%9.12M
11.59%2.41M
-1.15%2.15M
1.31%2.09M
3.51%2.48M
-12.29%8.79M
-4.22%2.16M
-17.57%2.17M
-17.17%2.06M
-9.25%2.39M
Research and development costs
-10.37%15.89M
14.86%5.12M
-24.21%3.74M
-11.98%3.6M
-19.21%3.44M
-9.02%17.73M
-32.83%4.46M
50.37%4.93M
5.20%4.09M
-25.23%4.25M
Depreciation amortization depletion
-28.57%90K
-70.97%9K
-32.26%21K
-6.45%29K
-3.13%31K
-0.79%126K
-11.43%31K
-3.13%31K
0.00%31K
6.67%32K
-Depreciation and amortization
-28.57%90K
-70.97%9K
-32.26%21K
-6.45%29K
-3.13%31K
-0.79%126K
-11.43%31K
-3.13%31K
0.00%31K
6.67%32K
Operating profit
5.77%-25.1M
-13.40%-7.53M
17.22%-5.91M
7.52%-5.72M
10.99%-5.94M
10.09%-26.64M
25.52%-6.64M
-19.98%-7.14M
3.53%-6.19M
20.07%-6.68M
Net non-operating interest income expense
-80.91%105K
-80.85%9K
-61.76%39K
-83.65%26K
-87.55%30K
-59.80%550K
-82.06%47K
-68.52%102K
-59.23%159K
-38.52%241K
Non-operating interest income
-80.91%105K
-80.85%9K
-61.76%39K
-83.65%26K
-87.55%30K
-59.80%550K
-82.06%47K
-68.52%102K
-59.23%159K
-38.52%241K
Other net income (expense)
-20,011.63%-8.56M
192,200.00%23.08M
-217,122.22%-19.53M
-214.00%-1.95M
-135.68%-523K
102.86%43K
100.74%12K
-35.71%9K
3,693.33%1.71M
3,019.15%1.47M
Gain on sale of security
-285.02%-7.93M
404.89%23.74M
-447.87%-19.55M
-214.98%-1.95M
-136.56%-532K
375.74%4.29M
388.47%4.7M
-356,900.00%-3.57M
4,611.11%1.7M
3,630.77%1.46M
Special income (charges)
---614K
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--614K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-146.51%-20K
-516.67%-50K
77.78%16K
-63.64%4K
-18.18%9K
-10.42%43K
-33.33%12K
-30.77%9K
22.22%11K
37.50%11K
Income before tax
-28.84%-33.56M
336.21%15.55M
-261.60%-25.4M
-76.89%-7.64M
-29.50%-6.44M
12.50%-26.05M
35.88%-6.58M
-25.23%-7.02M
27.73%-4.32M
37.21%-4.97M
Income tax
Net income
-28.84%-33.56M
336.21%15.55M
-261.60%-25.4M
-76.89%-7.64M
-29.50%-6.44M
12.50%-26.05M
35.88%-6.58M
-25.23%-7.02M
27.73%-4.32M
37.21%-4.97M
Net income continuous Operations
-28.84%-33.56M
336.21%15.55M
-261.60%-25.4M
-76.89%-7.64M
-29.50%-6.44M
12.50%-26.05M
35.88%-6.58M
-25.23%-7.02M
27.73%-4.32M
37.21%-4.97M
Minority interest income
Net income attributable to the parent company
-28.84%-33.56M
336.21%15.55M
-261.60%-25.4M
-76.89%-7.64M
-29.50%-6.44M
12.50%-26.05M
35.88%-6.58M
-25.23%-7.02M
27.73%-4.32M
37.21%-4.97M
Preferred stock dividends
Other preferred stock dividends
104K
0
Net income attributable to common stockholders
-29.24%-33.66M
334.63%15.45M
-261.60%-25.4M
-76.89%-7.64M
-29.50%-6.44M
12.50%-26.05M
35.88%-6.58M
-25.23%-7.02M
27.73%-4.32M
37.21%-4.97M
Basic earnings per share
84.97%-28.42
122.06%4.8287
64.02%-17
71.18%-12.25
65.84%-17.25
49.80%-189.14
82.93%-21.89
32.98%-47.25
43.71%-42.5
51.09%-50.5
Diluted earnings per share
84.97%-28.42
122.06%4.8287
64.02%-17
71.18%-12.25
65.84%-17.25
49.80%-189.14
82.93%-21.89
32.98%-47.25
43.71%-42.5
51.09%-50.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -5.77%25.1M13.40%7.53M-17.22%5.91M-7.52%5.72M-10.99%5.94M-10.09%26.64M-25.52%6.64M19.98%7.14M-3.53%6.19M-20.07%6.68M
Selling and administrative expenses 3.82%9.12M11.59%2.41M-1.15%2.15M1.31%2.09M3.51%2.48M-12.29%8.79M-4.22%2.16M-17.57%2.17M-17.17%2.06M-9.25%2.39M
-General and administrative expense 3.82%9.12M11.59%2.41M-1.15%2.15M1.31%2.09M3.51%2.48M-12.29%8.79M-4.22%2.16M-17.57%2.17M-17.17%2.06M-9.25%2.39M
Research and development costs -10.37%15.89M14.86%5.12M-24.21%3.74M-11.98%3.6M-19.21%3.44M-9.02%17.73M-32.83%4.46M50.37%4.93M5.20%4.09M-25.23%4.25M
Depreciation amortization depletion -28.57%90K-70.97%9K-32.26%21K-6.45%29K-3.13%31K-0.79%126K-11.43%31K-3.13%31K0.00%31K6.67%32K
-Depreciation and amortization -28.57%90K-70.97%9K-32.26%21K-6.45%29K-3.13%31K-0.79%126K-11.43%31K-3.13%31K0.00%31K6.67%32K
Operating profit 5.77%-25.1M-13.40%-7.53M17.22%-5.91M7.52%-5.72M10.99%-5.94M10.09%-26.64M25.52%-6.64M-19.98%-7.14M3.53%-6.19M20.07%-6.68M
Net non-operating interest income expense -80.91%105K-80.85%9K-61.76%39K-83.65%26K-87.55%30K-59.80%550K-82.06%47K-68.52%102K-59.23%159K-38.52%241K
Non-operating interest income -80.91%105K-80.85%9K-61.76%39K-83.65%26K-87.55%30K-59.80%550K-82.06%47K-68.52%102K-59.23%159K-38.52%241K
Other net income (expense) -20,011.63%-8.56M192,200.00%23.08M-217,122.22%-19.53M-214.00%-1.95M-135.68%-523K102.86%43K100.74%12K-35.71%9K3,693.33%1.71M3,019.15%1.47M
Gain on sale of security -285.02%-7.93M404.89%23.74M-447.87%-19.55M-214.98%-1.95M-136.56%-532K375.74%4.29M388.47%4.7M-356,900.00%-3.57M4,611.11%1.7M3,630.77%1.46M
Special income (charges) ---614K------------------0----------------
-Less:Other special charges --614K------------------------------------
Other non- operating income (expenses) -146.51%-20K-516.67%-50K77.78%16K-63.64%4K-18.18%9K-10.42%43K-33.33%12K-30.77%9K22.22%11K37.50%11K
Income before tax -28.84%-33.56M336.21%15.55M-261.60%-25.4M-76.89%-7.64M-29.50%-6.44M12.50%-26.05M35.88%-6.58M-25.23%-7.02M27.73%-4.32M37.21%-4.97M
Income tax
Net income -28.84%-33.56M336.21%15.55M-261.60%-25.4M-76.89%-7.64M-29.50%-6.44M12.50%-26.05M35.88%-6.58M-25.23%-7.02M27.73%-4.32M37.21%-4.97M
Net income continuous Operations -28.84%-33.56M336.21%15.55M-261.60%-25.4M-76.89%-7.64M-29.50%-6.44M12.50%-26.05M35.88%-6.58M-25.23%-7.02M27.73%-4.32M37.21%-4.97M
Minority interest income
Net income attributable to the parent company -28.84%-33.56M336.21%15.55M-261.60%-25.4M-76.89%-7.64M-29.50%-6.44M12.50%-26.05M35.88%-6.58M-25.23%-7.02M27.73%-4.32M37.21%-4.97M
Preferred stock dividends
Other preferred stock dividends 104K0
Net income attributable to common stockholders -29.24%-33.66M334.63%15.45M-261.60%-25.4M-76.89%-7.64M-29.50%-6.44M12.50%-26.05M35.88%-6.58M-25.23%-7.02M27.73%-4.32M37.21%-4.97M
Basic earnings per share 84.97%-28.42122.06%4.828764.02%-1771.18%-12.2565.84%-17.2549.80%-189.1482.93%-21.8932.98%-47.2543.71%-42.551.09%-50.5
Diluted earnings per share 84.97%-28.42122.06%4.828764.02%-1771.18%-12.2565.84%-17.2549.80%-189.1482.93%-21.8932.98%-47.2543.71%-42.551.09%-50.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.61%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -